Literature DB >> 9065427

A conserved sequence motif in the integrin beta3 cytoplasmic domain is required for its specific interaction with beta3-endonexin.

M Eigenthaler1, L Höfferer, S J Shattil, M H Ginsberg.   

Abstract

Integrin signaling is mediated by interaction of integrin cytoplasmic domains with intracellular signaling molecules. Recently, we identified a novel 111-amino acid polypeptide, termed beta3-endonexin, which interacts selectively with the integrin beta3 cytoplasmic domain. In the present study we conducted a systematic mutational analysis of both the integrin beta3 cytoplasmic domain and beta3-endonexin to map sites required for interaction. The interaction of the full-length beta3 integrin subunit with beta3-endonexin in vitro required the beta3 cytoplasmic domain. In a yeast two-hybrid system, both membrane-proximal and membrane-distal residues of the beta3 cytoplasmic domain were necessary for interaction with beta3-endonexin. In particular, the membrane-distal NITY motif at beta3 756-759 was critical for the interaction. Exchange of beta3 residues 756-759 (NITY) for the corresponding residues in beta1 (NPKY) endowed the beta1 cytoplasmic domain with the ability to interact with beta3-endonexin. Conversely, exchange of the NPKY motif at beta1 772-775 for the NITY motif in beta3 abolished interaction of this chimeric cytoplasmic domain with beta3-endonexin. Because the NITY motif is present in the beta3 but not the beta1 cytoplasmic domain, these results explain the selective interaction of this cytoplasmic domain with beta3-endonexin. In addition, deletional analysis suggested that a core 91-residue sequence of beta3-endonexin is sufficient for specific binding to the beta3 cytoplasmic domain. These studies have identified a cytoplasmic domain sequence motif that specifies an integrin-specific protein-protein interaction.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9065427     DOI: 10.1074/jbc.272.12.7693

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

1.  Regulation of adenovirus membrane penetration by the cytoplasmic tail of integrin beta5.

Authors:  K Wang; T Guan; D A Cheresh; G R Nemerow
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

2.  Solution structures of the cytoplasmic tail complex from platelet integrin alpha IIb- and beta 3-subunits.

Authors:  Aalim M Weljie; Peter M Hwang; Hans J Vogel
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-30       Impact factor: 11.205

3.  Membrane-mediated structural transitions at the cytoplasmic face during integrin activation.

Authors:  Olga Vinogradova; Julia Vaynberg; Xiangming Kong; Thomas A Haas; Edward F Plow; Jun Qin
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-15       Impact factor: 11.205

4.  ARF Confers a Context-Dependent Response to Chemotherapy in Muscle-Invasive Bladder Cancer.

Authors:  Tomasz B Owczarek; Takashi Kobayashi; Ricardo Ramirez; Lijie Rong; Anna M Puzio-Kuter; Gopa Iyer; Min Yuen Teo; Francisco Sánchez-Vega; Jingqiang Wang; Nikolaus Schultz; Tian Zheng; David B Solit; Hikmat A Al-Ahmadie; Cory Abate-Shen
Journal:  Cancer Res       Date:  2017-01-12       Impact factor: 12.701

Review 5.  Structure and function of the platelet integrin alphaIIbbeta3.

Authors:  Joel S Bennett
Journal:  J Clin Invest       Date:  2005-12       Impact factor: 14.808

6.  Transmembrane-truncated alphavbeta3 integrin retains high affinity for ligand binding: evidence for an 'inside-out' suppressor?

Authors:  R J Mehta; B Diefenbach; A Brown; E Cullen; A Jonczyk; D Güssow; G A Luckenbach; S L Goodman
Journal:  Biochem J       Date:  1998-03-01       Impact factor: 3.857

Review 7.  Perspectives series: cell adhesion in vascular biology. Integrin signaling in vascular biology.

Authors:  S J Shattil; M H Ginsberg
Journal:  J Clin Invest       Date:  1997-07-01       Impact factor: 14.808

8.  beta(3)A-integrin downregulates the urokinase-type plasminogen activator receptor (u-PAR) through a PEA3/ets transcriptional silencing element in the u-PAR promoter.

Authors:  S Hapke; M Gawaz; K Dehne; J Köhler; J F Marshall; H Graeff; M Schmitt; U Reuning; E Lengyel
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

9.  NRIF3 is a novel coactivator mediating functional specificity of nuclear hormone receptors.

Authors:  D Li; V Desai-Yajnik; E Lo; M Schapira; R Abagyan; H H Samuels
Journal:  Mol Cell Biol       Date:  1999-10       Impact factor: 4.272

10.  The ability of integrin alpha(v)beta(3) To function as a receptor for foot-and-mouth disease virus is not dependent on the presence of complete subunit cytoplasmic domains.

Authors:  S Neff; B Baxt
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.